We and others have previously demonstrated that pulmonary fibroblasts derived from the lungs of patients with IPF and SSc express significantly lower steady-state levels of COX-2 RNA, compared with controls, basally and in response to TGF-β1 [6,31,32]. The gene discussed is PTGS2; the disease is systemic sclerosis.